FDA updates cybersecurity guidance for medical device makers
The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
The FBI has public resources available to help prevent exploitation by cybercriminals, who use artificial intelligence for deception. An infographic by the FBI…
Headline
A critical vulnerability has been identified in 7-Zip, a free software program used for archiving data, according to the National Institute of Standards and…
Headline
U.S. and international agencies Nov. 19 released a guide on mitigating potential cybercrimes from bulletproof hosting providers. A BPH provider is an internet…
Headline
A joint advisory issued yesterday by U.S. and international agencies provides updated guidance to defend against the Akira ransomware group, which…
Headline
The National Security Agency, Cybersecurity and Infrastructure Security Agency and international partners released joint guidance Oct. 30 on best practices for…
Headline
Microsoft issues security update addressing critical vulnerability impacting Windows server services
Microsoft has released a security update to address a critical remote code execution vulnerability impacting multiple versions of Windows Server Update…